An MRM ‐Based Cytokeratin Marker Assay as a Tool for Cancer Studies: Application to Lung Cancer Pleural Effusions

Conclusion and clinical relevanceAn MRM‐based CK assay for carcinoma studies can differentiate between the three lung cancer histological types using less‐invasive PE sampling providing potential therapy‐guiding information on patients that are inoperable.

Source: Proteomics. Clinical Applications - February 7, 2018 Category: Biochemistry Authors: Anna Perzanowska, Agnieszka Fatalska, Grzegorz Wojtas, Andrzej Lewandowicz, Agata Michalak, Grzegorz Krasowski, Christoph H. Borchers, Michal Dadlez, Dominik Domanski Tags: RESEARCH ARTICLE Source Type: research